Načítá se...
Clinical characteristics of rheumatic syndromes associated with checkpoint inhibitors therapy
Compared with conventional cancer therapies, the spectrum of toxicities observed with checkpoint inhibitors is unique and can affect any organ system. Arthralgia and myalgia were by far the most commonly reported rheumatic immune-related adverse events in clinical trials, and there is now a growing...
Uloženo v:
| Vydáno v: | Rheumatology (Oxford) |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6900916/ https://ncbi.nlm.nih.gov/pubmed/31816082 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/kez295 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|